Inventor · disambiguated record
Leah E. Appel
Also filed as: APPEL LEAH E · APPEL LEAH ELIZABETH · APPEL Leah
17 granted patents·23 pending applications·471 citations·filing 1992–2022
94Inventor score
Top patents by PatentIndex Score
40 records- 0198US6706283B1Controlled release by extrusion of solid amorphous dispersions of drugsPFIZER·Filed 2000·Granted Mar 16, 2004·202 cites·71 claims
- 0295US6984403B2Azithromycin dosage forms with reduced side effectsPFIZER·Filed 2004·Granted Jan 10, 2006·85 cites·48 claims
- 0390US9211261B2Immediate release dosage forms containing solid drug dispersionsAPPEL LEAH E·Filed 2007·Granted Dec 15, 2015·30 cites·16 claims
- 0488US9028870B2Hydrogel-driven drug dosage formAPPEL LEAH E·Filed 2010·Granted May 12, 2015·14 cites·3 claims
- 0586US7550158B2Controlled release by extrusion of solid amorphous dispersions of drugsBEND RES INC·Filed 2004·Granted Jun 23, 2009·19 cites·8 claims
- 0685US7887844B2Multiparticulate crystalline drug compositions having controlled release profilesPFIZER·Filed 2004·Granted Feb 15, 2011·16 cites·15 claims
- 0785US7625507B2Extrusion process for forming chemically stable drug multiparticulatesPFIZER·Filed 2004·Granted Dec 1, 2009·17 cites·19 claims
- 0882US5256440AProcess for producing a tablet core apertureMERCK & CO INC·Filed 1992·Granted Oct 26, 1993·71 cites·17 claims
- 0981US7736672B2Multiparticulate compositions with improved stabilityPFIZER·Filed 2004·Granted Jun 15, 2010·11 cites·19 claims
- 1075US2023133629A1Palatable compositions including sodium phenylbutyrate and uses thereofACER THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1172US8236349B2Taste-masked drugs in rupturing multiparticulatesAPPEL LEAH ELIZABETH·Filed 2005·Granted Aug 7, 2012·1 cites·14 claims
- 1271US11202767B2Methods of treating urea cycle disorders and maple syrup urine diseaseACER THERAPEUTICS INC·Filed 2021·Granted Dec 21, 2021·0 cites·27 claims
- 1371US11154521B2Palatable compositions including sodium phenylbutyrate and uses thereofACER THERAPEUTICS INC·Filed 2021·Granted Oct 26, 2021·0 cites·27 claims
- 1471US7951403B2Method of making pharmaceutical multiparticulatesPFIZER·Filed 2004·Granted May 31, 2011·5 cites·6 claims
- 1570US2010003331A1Sustained release dosage forms of ziprasidonePFIZER·Filed 2009·Application pending·0 cites
- 1667US11433041B2Palatable compositions including sodium phenylbutyrate and uses thereofACER THERAPEUTICS[ ] INC·Filed 2020·Granted Sep 6, 2022·0 cites·24 claims
- 1767US9445998B2Pharmaceutical dosage forms comprising a low-solubility drug and a polymerBEND RES INC·Filed 2014·Granted Sep 20, 2016·0 cites·7 claims
- 1861US2011313009A1Nsaid dose unit formulations with h2-receptor antagonists and methods of useTIDMARSH GEORGE·Filed 2009·Application pending·0 cites
- 1960US2008015343A1Azithromycin dosage forms with reduced side effectsPFIZER·Filed 2007·Application pending·0 cites
- 2060US2007190129A1Sustained release dosage forms of ziprasidonePFIZER·Filed 2004·Application pending·0 cites
- 2158US2008299188A1Controlled release dosage forms combining immediate release and sustainted release of low-solubility drugPFIZER·Filed 2007·Application pending·0 cites
- 2257US2009142404A1Pharmaceutical dosage forms comprising a low-solubility drug and a polymerPFIZER·Filed 2005·Application pending·0 cites
- 2357US2005152982A1Controlled release multiparticulates formed with dissolution enhancersPFIZER·Filed 2004·Application pending·0 cites
- 2457US2005123615A1Controlled release dosage forms of azithromycinPFIZER·Filed 2004·Application pending·0 cites
- 2557US2005123616A1Azithromycin multiparticulate dosage forms by liquid-based processesPFIZER·Filed 2004·Application pending·0 cites
- 2657US2005158391A1Azithromycin multiparticulate dosage forms by melt-congeal processesPFIZER·Filed 2004·Application pending·0 cites
- 2756US2006029677A1Azithromycin dosage forms with reduced side effectsPFIZER·Filed 2005·Application pending·0 cites
- 2856US2006039988A1Azithromycin dosage forms with reduced side effectsPFIZER·Filed 2005·Application pending·0 cites
- 2956US2024342104A1Dosage form for improving palatability of drug substanceACER THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3054US2017266115A1Palatable compositions including sodium phenylbutyrate and uses thereofACER THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3153US11116728B2Multiparticulates of spray-coated drug and polymer on a meltable coreBEND RES INC·Filed 2019·Granted Sep 14, 2021·0 cites·11 claims
- 3253US2004052845A1Hydrogel-driven drug dosage formFiled 2001·Application pending·0 cites
- 3353US2003086972A1Hydrogel-driven drug dosage formFiled 2001·Application pending·0 cites
- 3453US2008199527A1Enteric Coated Azithromycin MultiparticulatesPFIZER·Filed 2005·Application pending·0 cites
- 3551US2010233272A1Dosage forms comprising celecoxib providing both rapid and sustained pain reliefAPPEL LEAH ELIZABETH·Filed 2008·Application pending·0 cites
- 3647US2002015731A1Hydrogel-Driven Drug Dosage FormFiled 2000·Application pending·0 cites
- 3746US2003224043A1Immediate release dosage forms containing solid drug dispersionsPFIZER·Filed 2003·Application pending·0 cites
- 3845US2009142401A1Multiparticulates comprising low-solubility drugs and carriers that result in rapid drug releaseAPPEL LEAH ELIZABETH·Filed 2006·Application pending·0 cites
- 3943US10357462B2Multiparticulates of spray-coated drug and polymer on a meltable coreFRIESEN DWAYNE THOMAS·Filed 2007·Granted Jul 23, 2019·0 cites·11 claims
- 4038US2011027372A1Multiparticulates comprising low-solubility drugs and carriers that result in rapid drug releaseAPPEL LEAH ELIZABETH·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Leah E. Appel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →